Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04105153Completed
Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC
EGFR Positive Non-small Cell Lung Cancer
PrincipalinvestigatorStart date: 2019-04-15

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University Hospital Heidelberg

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Haichuan Su, PhD

Tang-Du Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

EGFR Positive Non-small Cell Lung Cancer
Similarity Score30%

Jiang Fan, MD

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

EGFR Positive Non-small Cell Lung Cancer
Similarity Score30%

Luis Rojas, MD

Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo

Moderately Similar
1 trials

Shared therapeutic areas:

EGFR Positive Non-small Cell Lung Cancer
Similarity Score30%

Shugeng Gao

Cancer Hospital Chinese Academy of Medical Science

Moderately Similar
2 trials

Shared therapeutic areas:

EGFR Positive Non-small Cell Lung Cancer
Similarity Score30%

Liu Wei, MD

Hebei Provincal Tumor Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

EGFR Positive Non-small Cell Lung Cancer
Similarity Score30%

Xiaohua Hu, MD

First Affiliated Hospital of Guangxi Medical University

Moderately Similar
2 trials

Shared therapeutic areas:

EGFR Positive Non-small Cell Lung Cancer
Similarity Score30%

Fang Jian, MD

Peking University Cancer Hospital & Institute

Moderately Similar
1 trials

Shared therapeutic areas:

EGFR Positive Non-small Cell Lung Cancer
Similarity Score30%

Nong Yang, MD

Hunan Cancer Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

EGFR Positive Non-small Cell Lung Cancer
Similarity Score30%

Jiao Shunchang, MD

Chinese People's Liberation Army (PLA) General Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

EGFR Positive Non-small Cell Lung Cancer
Similarity Score30%

Daniel Tan, BSc, MBBS, PhD

National Cancer Centre Singapore (Lead Sponsor)

Moderately Similar
1 trials

Shared therapeutic areas:

EGFR Positive Non-small Cell Lung Cancer
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04105153PrincipalInvestigator

Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC

EGFR Positive Non-small Cell Lung Cancer
Completed

All 1 trials loaded